gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · SMTIHealthcareOrthopedic & Surgical Supplies

Sanara MedTech Inc. Common Stock (SMTI)

$32.33+0.50%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$32.17▲ 10.97% in range
Nov 3, 2025Low $16.34 · High $35.28Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Sanara MedTech closed at $32.33 on Nov 4, up 0.50%, 8.4% below its 52-week closing high. Volume of 120.4K shares was 0.91× its 20-day average (close to normal).

Split-adjusted performance: -7.6% over one month, +68.8% over six months, +11.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $28.14M, up 9.0% from a year earlier, with a net margin of -1.6%.

Short interest was 374.8K shares at the Oct 15 settlement, up 5.7% from the prior report (7.8% of float, 1.8 days to cover).

Market cap$297.0M9.2M shares
Revenue · quarter$28.1M+9.0% YoY
Diluted EPS$-0.05—
P/E · TTM—P/S 2.7×
Net margin-1.6%Gross 93.0%
Dividend yieldNone
52-week range16.34 – 35.28−8.4% from high
Volume120.4K0.91× 20-day avg
Volatility · 60d13.7%Annualised
Short % of float7.8%1.8 days to cover
Net cash-$31.6MCash $15.4M
Next earnings—Not scheduled
Split-adjusted performance
1W −1.7%1M −7.6%3M −5.2%6M +68.8%YTD +38.5%1Y +11.5%3Y +22.8%5Y −11.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum100
Revenue growth42
Net margin53
Value (low P/E)—
Size52

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →
Shares short374.8K+5.7% vs prior
Days to cover1.8Settled Oct 15
% of float7.8%
Short vol. 10d50.4%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SMTISanara MedTech$32.33+0.50%+68.8%+9.0%−1.6%—$297.0M
INGNInogen$7.22+2.85%+1.5%+3.0%−4.0%—$191.6MCompare
AVRAnteris Technologies Global$6.12+9.29%−4.2%+63.3%−2883.4%—$596.4MCompare
LAKELakeland Industries$8.93−0.11%−7.3%−4.5%−9.8%—$88.7MCompare
NTRBNutriband$6.08−3.34%+53.1%−29.7%−201.3%—$73.9MCompare
CNXUConexeu Sciences$2.22−6.72%————$68.4MCompare
CDRECadre Holdings$30.84−0.71%0.0%+31.8%5.5%36.6$1.32BCompare
ENOVEnovis$24.42+16.90%−1.7%+3.2%−0.2%—$1.41BCompare
SPAISafe Pro Group$3.05−3.79%−31.8%+1336.2%−237.9%—$62.1MCompare

News about Sanara MedTech

All news →
Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their ShareholdersGlobeNewswire Inc. · Aug 5, 2026▼ NegativeHalper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their ShareholdersGlobeNewswire Inc. · Aug 4, 2026▼ NegativeBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)GlobeNewswire Inc. · Jul 30, 2026▼ NegativeSanara MedTech (SMTI) Q1 2026 Earnings TranscriptThe Motley Fool · Jun 2, 2026▲ PositiveSMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law FirmGlobeNewswire Inc. · May 8, 2026▼ Negative

Quick answers

What does Sanara MedTech do?
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments.
What is SMTI's market cap?
$297.05M, based on the Nov 4 close of $32.33.
Does Sanara MedTech pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SMTI is sold short?
374.8K shares, 7.8% of float, as of Oct 15, 2026.
What sector is SMTI in?
Healthcare, in the Orthopedic & Surgical Supplies industry.

About Sanara MedTech

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

HQ: Fort Worth, TX108 employeesListed Nov 2, 2020sanaramedtech.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology